REVIEW
|
doi:10.20944/preprints202201.0303.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
Inflammation; NF-κB; drug repurposing; drug development; autoimmunity; COVID-19; multiple sclerosis; rheumatoid arthritis
Online: 20 January 2022 (11:16:25 CET)